Oxaliplatin Enrolling by Invitation Phase 3 Trials for Rectal Neoplasms Malignant / Rectal Carcinoma / Rectum Carcinoma Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04135313Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
NCT04134897Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
NCT04103697Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer